News

Ms Hamberg joined LifeCycle Pharma in June 2008 and took over the position as chief medical officer in November 2008. In connection with Ms Hamberg’s resignation, Anderson Gaweco,

Aegis said that Discoverant is designed to help manage pharmaceutical and biopharmaceutical manufacturing processes. It enables on-demand access to, and analysis of, data in disparate production data sources

Mr Lin currently serves as director and CEO for General Biologicals. Mr Lin served as chairman of General Biologicals for 15 years and was CEO of Megamedia for

This collaboration will leverage the combination of genetic data and clinical oncology expertise from MD Anderson with supercomputers and advanced machine-learning software from Gene Network Sciences (GNS). Financial

The Maestro-03 US pivotal Phase III clinical trial is a randomized, double-blind study that has completed recruitment of approximately 510 patients at 67 clinical sites who will be

The CE Mark gives Intrinsic approval to distribute the Barricaid throughout the EU and in other countries that recognize the CE Mark. According to Intrinsic Therapeutics, the Barricaid

The financing will underwrite the completion of Serdaxin’s subsequent trials required to bring the treatment through regulatory approval and then to patients. The funding for the development of

In the first phase of this collaboration, the companies will test the feasibility of smart patch-based transdermal delivery of a peptide drug candidate in animal models. Upon completion

Data was compiled at 12 and 24 months for 593 patients and 177 patients respectively from the registry study, which enrolled a broad spectrum of patients, including those